Plantar verrucous skin carcinoma is a rare, slow-growing skin cancer that usually appears on the sole of the foot. It often looks like a stubborn wart or thick rough patch, and early symptoms of plantar verrucous skin carcinoma can include pain, tenderness, or trouble walking. Many people only realize later that their symptoms were connected to plantar verrucous skin carcinoma because it can be present for months or even years before it is diagnosed. It most often affects adults, and it rarely spreads to distant parts of the body, but it can grow deeply into nearby tissue if untreated. Treatment for plantar verrucous skin carcinoma usually involves surgery to remove it, and some people also need close follow-up to watch for recurrence.
How many people live with Plantar verrucous skin carcinoma?
Worldwide and U.S. estimates for how many people are living with plantar verrucous skin carcinoma are not consistently reported by a single authoritative source. This is a very rare skin cancer of the sole of the foot, and the medical literature is made up mostly of case reports and small case series rather than population counts.
Overview
Plantar verrucous skin carcinomaSymptoms
Plantar verrucous skin carcinoma often looks like a stubborn wart or thick callus on the sole. It may slowly enlarge, crack, bleed, smell unpleasant, or hurt when walking. Early symptoms of plantar verrucous skin carcinoma can be easy to miss.
Outlook and prognosis
Plantar verrucous skin carcinoma often grows slowly and rarely spreads to distant parts of the body, so outlook is usually good when it is found and fully removed. The main long-term concern is local recurrence, so regular follow-up is important.
Causes and risk factors
Plantar verrucous skin carcinoma may be linked to long-standing human papillomavirus infection, especially some wart-related types. Risk can also rise with chronic pressure, repeated trauma, wound healing, or long-term inflammation on the sole. Smoking and weakened immunity may add risk.
Genetic influences
Genetics are not thought to be a major driver of plantar verrucous skin carcinoma. Unlike some cancers, inherited genetic variations have not been clearly linked, and risk seems more related to long-term local skin changes and environmental factors.
Diagnosis
Plantar verrucous skin carcinoma is usually diagnosed with a skin exam and a biopsy, where a small tissue sample is checked under a microscope. Imaging may be used to see how deep it goes.
Treatment and drugs
Plantar verrucous skin carcinoma is usually treated with surgery to remove the growth while preserving as much healthy tissue as possible. Some people also need skin checks afterward. If it has spread or returned, treatment may be more extensive.
Symptoms
A rough spot on the sole that keeps thickening or hurting with each step can be easy to mistake for a stubborn wart or callus. In plantar verrucous skin carcinoma, the area usually grows very slowly but does not go away, and it may start to interfere with walking or standing. You might notice small changes at first, such as a patch that feels firmer, splits open, or keeps coming back after wart treatment.
The area often looks like a thick, rough wart or callus on the sole, with a bumpy or uneven surface. It may feel firmer and more fixed in place than ordinary dry skin.
Plantar verrucous skin carcinoma usually grows slowly over months or even years rather than appearing overnight. Even when growth is gradual, the spot tends to persist and become more noticeable instead of clearing.
Standing or walking can make the area sore, tender, or feel like you are stepping on a pebble. The discomfort may build up after a long day on your feet.
The skin may split, form deep cracks, or develop an open area that does not heal well. This can sting after a shower or make each step feel sharp.
How people usually first notice Plantar verrucous skin carcinoma?
For many people, plantar verrucous skin carcinoma is first noticed as a stubborn wart-like growth on the sole of the foot that slowly gets bigger and does not go away. It may look thick, rough, or cauliflower-like, and some people notice pain when walking, tenderness, cracking, bleeding, or a sore that keeps coming back despite wart treatments. Because the first signs of plantar verrucous skin carcinoma can seem harmless at first, a lesion that persists for months, deepens, or starts draining should be checked by a doctor.
Types of Plantar verrucous skin carcinoma
Plantar verrucous skin carcinoma is usually not divided into formal disease subtypes. Instead, doctors describe it by how it looks and how deeply it has grown into nearby tissue. Symptoms don’t always look the same for everyone. Early symptoms of plantar verrucous skin carcinoma often resemble a stubborn wart or callus, while more advanced disease can interfere with walking and standing.
Wart-like growth
This pattern looks like a rough, thick bump on the sole that may seem like a plantar wart that does not go away. It often grows slowly and may not hurt much at first. Many living with plantar verrucous skin carcinoma notice it keeps coming back or enlarging despite usual skin treatments.
Thickened plaque
Some people develop a broader patch of hardened, overgrown skin rather than a single bump. The area can feel firm, uneven, and tender when pressure is placed on it. Daily life often makes the differences between symptom types clearer, especially during long periods of walking or standing.
Ulcerated lesion
In some cases, the surface begins to crack, bleed, or form an open sore. This can bring drainage, odor, or more noticeable pain. These changes are often a sign that the lesion is becoming more aggressive locally.
Deep invasive disease
As plantar verrucous skin carcinoma grows, it can press into deeper soft tissue and, rarely, bone. People may notice worsening pain, trouble bearing weight, or a limp. Not everyone will experience every type.
Can I slow down the onset of symptoms?
Probably not in a proven way: for plantar verrucous skin carcinoma, a rare slow-growing skin cancer on the sole of the foot, there is no strong evidence that lifestyle changes or medicines can meaningfully delay when symptoms begin. Research suggests the best way to lower risk is to avoid long-lasting foot irritation or repeated injury and to get sores, thick wart-like spots, or areas that keep cracking or bleeding checked early, but this may reduce risk or help find it sooner rather than prevent it. There are no well-established preventive drugs or routine screening programs for this cancer, but seeing a skin doctor or foot doctor promptly for a spot that does not heal is still a sensible step.
What genetics can tell you about symptoms
For plantar verrucous skin carcinoma, genetics usually cannot tell doctors much about which symptoms you will have, how severe they will be, or when they will start. In most people, day-to-day problems such as a slow-growing wart-like lump on the sole, pain with walking, or skin breakdown are driven more by where the tumor is, how deep it grows, and how long it has been present than by an inherited gene change. While some DNA changes may be found in the tumor itself, they are not currently used in routine care to reliably predict symptoms for this condition.
Causes and risk factors
The exact causes of plantar verrucous skin carcinoma are not fully clear, but it often develops in skin on the sole that has had long-term irritation or damage. Longstanding plantar warts, chronic wounds, scars, pressure, and repeated rubbing may raise the risk. Some cases are linked to human papillomavirus, or HPV, but this is not found in everyone. Older age, a weakened immune system, and rare inherited conditions that make skin cancer more likely can also play a part. Risk can vary widely from person to person, and good foot care and treatment of stubborn sores or warts may help lower risk.
What are the most common causes or risk factors?
There is no well-known inherited genetic cause for plantar verrucous skin carcinoma, which is a rare, slow-growing skin cancer on the sole of the foot. The strongest linked risk factors are long-lasting irritation or inflammation in the area, such as chronic wounds, scars, repeated rubbing or pressure, or a wart-like spot that does not heal; in some people, certain human papillomavirus, or HPV, infections may also play a part. It tends to be seen more often in older adults and in people with a weakened immune system.
Environmental and biological risk factors
Plantar verrucous skin carcinoma is a rare skin cancer that usually develops on the sole of the foot. Doctors often group risks into internal (biological) and external (environmental). The main risk factors for plantar verrucous skin carcinoma include long-term skin damage, ongoing inflammation, and conditions that weaken the body’s immune defenses.
This condition is seen more often in older adults, after many years of skin stress and repair. The longer skin has been exposed to damage or inflammation, the more opportunity abnormal cells have to build up.
Plantar verrucous skin carcinoma has been reported more often in men than in women. The reason is not fully understood, but biological sex appears to influence risk.
A reduced immune system can make it harder for the body to remove damaged or abnormal skin cells. This can raise the risk of squamous cell cancers, including this uncommon plantar type.
Long-standing ulcers, scars, draining tracts, or areas of repeated infection can keep the skin inflamed for years. Skin that is constantly trying to heal has a higher chance of developing cancerous change over time.
Genetic risk factors
Plantar verrucous skin carcinoma usually does not come from one known inherited gene, and most cases appear to happen sporadically. Carrying a genetic change doesn’t guarantee the condition will appear. What doctors know more clearly is that a few rare inherited conditions can raise the risk of squamous skin cancers overall, which may include this uncommon tumor on the sole of the foot. When people ask about genetic risk factors for plantar verrucous skin carcinoma, the main concerns are family history and rare syndromes that affect DNA repair, skin growth, or immune defense.
No single gene: Researchers have not identified one inherited gene that explains most cases of plantar verrucous skin carcinoma. In many people with this cancer, no clear hereditary cause is found.
Family history: A family history of squamous skin cancer can suggest a shared inherited tendency, but by itself it does not strongly predict this rare plantar form. The pattern matters more when several close relatives have had related skin cancers.
DNA repair syndromes: Rare inherited disorders that weaken DNA repair can make skin cells more likely to collect cancer-causing changes. One example is xeroderma pigmentosum, although plantar verrucous skin carcinoma is still uncommon even in these conditions.
Inherited wart disorders: Rare genetic conditions that cause unusually persistent wart-like skin growths can also raise the risk of some squamous skin cancers. A well-known example is epidermodysplasia verruciformis, but this link is rare and not specific to the sole.
Immune defects: Some inherited immune system disorders reduce the body’s ability to control abnormal skin cell growth. This may increase the broader risk of squamous skin cancers, though a direct inherited link to plantar verrucous skin carcinoma is not common.
Lifestyle risk factors
For plantar verrucous skin carcinoma, the evidence on lifestyle risks is limited because this is a rare skin cancer. Still, some day-to-day habits may raise risk by promoting long-term irritation, delayed healing, or late recognition of suspicious lesions on the sole. When people ask about lifestyle risk factors for plantar verrucous skin carcinoma, the most relevant issues are repeated foot trauma, smoking, poor foot care, and delaying medical evaluation of a persistent wart-like growth.
Ongoing pressure, rubbing, or minor trauma from poorly fitting shoes or high-impact repetitive activity can keep the skin on the sole chronically inflamed. Over time, this may make a persistent lesion harder to heal and easier to overlook as a simple callus or wart.
Ignoring or self-treating a stubborn plantar wart-like lesion for months or years can delay diagnosis of plantar verrucous skin carcinoma. Late evaluation may allow deeper local growth and make treatment more extensive.
Tobacco use can impair circulation and wound healing in the feet. This may prolong chronic skin damage and reduce the skin's ability to recover from repeated injury.
Infrequent foot inspection, continued walking on painful lesions, and not addressing cracks or chronic sores can allow abnormal tissue changes to persist. Good foot care matters because these cancers often resemble benign plantar lesions early on.
Risk prevention
Plantar verrucous skin carcinoma is a rare, slow-growing skin cancer that appears on the sole of the foot. There is no guaranteed way to prevent it, but risk can be lowered by protecting the skin on your feet, treating long-lasting foot problems early, and getting unusual lesions checked without delay. This matters because what looks like a stubborn wart or cracked area can sometimes turn out to be one of the early symptoms of plantar verrucous skin carcinoma. Prevention works best when combined with regular check-ups.
Look at the soles of your feet regularly, especially if you have a thick, wart-like area that bleeds, cracks, or keeps coming back. Early review can help catch plantar verrucous skin carcinoma before it grows deeper into nearby tissue.
A sore, ulcer, or rough patch on the foot that does not heal should be assessed rather than repeatedly self-treated. Ongoing irritation and delayed diagnosis can allow plantar verrucous skin carcinoma to persist unnoticed.
Try to reduce repeated friction, pressure, and injury to the soles by wearing well-fitting shoes and managing calluses safely. Protecting the skin may lower the chance of long-term damage that can set the stage for plantar verrucous skin carcinoma.
Cutting, burning, or using strong acid treatments on a lesion you think is a wart can damage the area and delay proper diagnosis. If a spot is enlarging or painful, have it checked by a clinician instead.
Can you prevent Plantar verrucous skin carcinoma?
Not completely. This rare skin cancer on the sole of the foot does not have one clear cause, so there is no sure way to prevent it, but treating long-lasting sores, wart-like growths, or thick patches early may help lower the risk. Good foot care and avoiding repeated injury or ongoing irritation to the bottom of the foot may also help, especially for people living with diabetes or poor feeling in their feet.
Transmission
Plantar verrucous skin carcinoma is not contagious, so it does not pass from one person to another through touch, shared floors, towels, shoes, or sexual contact. Many living with it first worry they picked up a stubborn wart at the gym or pool, but this cancer itself is not an infection.
It also is not usually something inherited in families. In most cases, plantar verrucous skin carcinoma develops in the skin over time rather than being transferred, although a doctor may still check for other causes of a wart-like growth on the foot.
When to test your genes
For plantar verrucous skin carcinoma, routine inherited genetic testing is usually not needed because this cancer is not typically driven by an inherited gene change. Genetic or molecular testing may be considered if the tumor is advanced, keeps coming back, or looks unusual under the microscope, because results can sometimes help guide treatment.
Diagnosis
Plantar verrucous skin carcinoma is usually diagnosed after a long-lasting wart-like spot on the sole keeps growing, starts hurting, or does not improve with standard treatment. For many, the first step comes when everyday activities start feeling harder. Because it can look like a stubborn plantar wart or thick callused skin, the diagnosis of plantar verrucous skin carcinoma often depends on careful exams and a skin sample.
A doctor checks the size, shape, thickness, and exact location of the lesion on the bottom of the foot. They also look for warning signs such as slow enlargement, deep cracking, bleeding, drainage, or pain with walking.
Doctors ask how long the spot has been there and whether it has changed over time. Prior treatments, repeated “wart” removal, and trouble standing or walking can help show that this may be more than a common wart.
The key test is a biopsy, where part or all of the growth is removed and examined under a microscope. This is usually the most important step in how plantar verrucous skin carcinoma is diagnosed because the surface alone can be misleading.
Sometimes a shallow sample misses the deeper part of the tumor, so a larger or deeper biopsy may be needed. This helps doctors tell verrucous carcinoma apart from a benign wart or other forms of skin cancer.
How is Plantar verrucous skin carcinoma diagnosed?
Plantar verrucous skin carcinoma is usually diagnosed after a doctor examines a thick, wart-like growth on the sole of the foot and asks how long it has been there, whether it has been growing, and if it bleeds, hurts, or keeps coming back. The diagnosis is confirmed by taking a small piece of the growth, or sometimes removing more of it, and checking the tissue under a microscope to see if it is cancer. If the area is large or has been there for a long time, imaging such as an X-ray or scan may be used to see how deep it goes and whether nearby tissue or bone is affected.
Stages of Plantar verrucous skin carcinoma
Plantar verrucous skin carcinoma is usually described by cancer stage rather than by a fixed set of day-to-day symptom phases. The stage depends on how deep the tumor has grown, whether it has reached nearby tissues, and whether it has spread to lymph nodes or other parts of the body. Different tests may be suggested to help confirm the diagnosis and stage, such as a skin biopsy, imaging, and a close exam of the foot. Early symptoms of plantar verrucous skin carcinoma can look like a stubborn wart or thick rough patch, so staging often starts only after the growth is tested.
Stage 0
Abnormal cells are limited to the top layer of skin and have not grown deeper. This is an in situ stage and is uncommon for verrucous tumors of the foot. Treatment at this point is usually aimed at complete removal before deeper invasion develops.
Stage 1
The plantar verrucous skin carcinoma is still small and confined to the skin of the foot. It has not spread to lymph nodes or distant organs. Many living with this stage have a slow-growing lesion that may be painful when walking or standing.
Stage 2
The tumor is larger or has grown more deeply into nearby tissue, but it still has not spread to lymph nodes or distant sites. On the sole, this can mean a mass that keeps returning, cracks, bleeds, or makes daily walking harder. Doctors also look for features that suggest a higher chance of local damage.
Stage 3
The cancer has spread to a nearby lymph node, or it has grown into deeper nearby structures such as soft tissue, tendon, or bone in the foot. For many, this can mean more swelling, pain, or trouble bearing weight. At this stage, treatment often becomes more involved because both the main tumor and nearby spread need attention.
Stage 4
The plantar verrucous skin carcinoma has spread more widely, such as to distant lymph nodes, the lungs, or other organs. This stage is uncommon because verrucous carcinoma usually grows slowly and tends to spread late, if at all. Care is focused on controlling the cancer, easing symptoms, and preserving function as much as possible.
Outlook and prognosis
The outlook for plantar verrucous skin carcinoma is generally favorable when it is diagnosed early and completely removed, because it usually grows slowly and has a low risk of spreading to distant sites. However, it can be locally aggressive, invading deeply into soft tissue and sometimes bone if treatment is delayed, which can increase the need for extensive surgery and impair walking. Local recurrence is the main long-term concern, especially after incomplete excision, so careful follow-up is important. Metastasis is uncommon, and death from this tumor is rare, but advanced neglected cases can cause major destruction of the foot and serious disability. Overall, prognosis is best with prompt diagnosis, complete surgical treatment, and monitoring for recurrence.
Long-term effects
Plantar verrucous skin carcinoma often affects day-to-day life because it develops on the sole of the foot, where pressure, walking, and standing matter most. Over time, daily routines may change if the growth comes back, becomes painful, or requires repeated treatment. The long-term picture is often one of slow local growth rather than spread to distant organs, but untreated disease can damage deeper tissue and make walking harder.
Plantar verrucous skin carcinoma can come back in the same area, even after treatment. This is one of the most important long-term effects of plantar verrucous skin carcinoma, so doctors often watch the site closely over time.
Because the tumor is on the bottom of the foot, many living with plantar verrucous skin carcinoma may have lasting pain, tenderness, or pressure discomfort when standing or walking. Some may find that a short walk, work shift, or time on hard floors becomes harder than it used to be.
If the cancer grows for a long time, it can slowly destroy nearby skin and soft tissue. This can lead to a larger wound, drainage, odor, or trouble with healing after treatment.
In deeper or long-standing cases, the cancer may grow into structures under the skin, including bone. When that happens, treatment is often more extensive and long-term foot function can be more limited.
How is it to live with Plantar verrucous skin carcinoma?
Living with plantar verrucous skin carcinoma can feel like dealing with a sore, stubborn spot on the sole that does not heal, and over time it may make every step more uncomfortable. For many people, this can mean pain with walking or standing, trouble exercising or working on their feet, and repeated appointments for biopsies, treatment, wound care, and follow-up because this rare skin cancer often grows slowly but can be locally destructive if ignored. Family members or other close contacts are not at risk of “catching” the cancer, but they may be affected in practical ways, helping with mobility, transportation, dressing changes, and the stress that can come with a cancer diagnosis.
Treatment and drugs
Plantar verrucous skin carcinoma is usually treated by removing the growth completely, most often with surgery, because it tends to grow slowly but can keep spreading deeper into the skin and tissue of the sole if it is left alone. For many people, treatment begins with small daily steps, but with this condition the main step is often planning the right procedure, which may range from standard surgical removal to a tissue-sparing approach such as Mohs surgery in centers that offer it. Medicines do not usually cure plantar verrucous skin carcinoma on their own, though doctors may use pain relief, wound care, or antibiotics if an infection develops around the area. After treatment, regular follow-up visits are important to watch for the cancer coming back, since early treatment of recurrent plantar verrucous skin carcinoma can help limit further surgery and protect walking comfort.
Can you cure Plantar verrucous skin carcinoma?
Often, yes: this rare, slow-growing skin cancer on the sole of the foot can often be cured if it is found early and fully removed, usually with surgery. The main goal of treatment is to take out all of the cancer, because if any is left behind, it can come back. Ongoing checkups are important to watch for return and treat it again if needed.
Non-drug treatment
Living with plantar verrucous skin carcinoma can make every step uncomfortable, especially if the growth is on a weight-bearing part of the foot. Treatment usually focuses on removing the cancer fully while protecting walking, balance, and wound healing as much as possible. For many, treatment begins not at the pharmacy, but with procedures and supportive care planned by a skin cancer and foot care team. Because this cancer can look like a stubborn wart, early symptoms of plantar verrucous skin carcinoma may delay diagnosis, so follow-up after treatment matters.
Surgery is the main treatment for plantar verrucous skin carcinoma and aims to remove the whole tumor with a rim of healthy tissue. The exact operation depends on the size, depth, and location of the growth.
In some cases, Mohs surgery may be used to remove the cancer layer by layer while checking each layer under a microscope. This can help spare as much healthy skin as possible, which is especially important on the sole of the foot.
After the tumor is removed, some people need a skin graft or flap to help close the wound and support healing. This can be important when the treated area is large or in a spot that takes pressure during walking.
Special footwear, padding, crutches, or a walking boot may be used to keep weight off the area while it heals. Simple routines—like keeping pressure off the wound or changing dressings as advised—can have lasting benefits.
Your genes may have an impact on how drugs work for you
For people living with plantar verrucous skin carcinoma, treatment is usually based more on where the growth is, how deep it goes, and whether it has come back than on inherited gene differences. At this time, there are no well-established, routine gene tests used to predict how common medicines for this condition will work or what side effects they may cause. If medicine is used as part of care, your team will usually adjust treatment based on how the area responds and on your overall health, rather than on a known genetic result.
Pharmacological treatments
For most people with plantar verrucous skin carcinoma, medicines are not the main treatment, because this slow-growing skin cancer is usually treated with surgery. Drug treatment for plantar verrucous skin carcinoma may be considered when surgery is not a good option, when the cancer comes back, or when it has spread. If one option isn’t effective, second-line or alternative drugs may be offered.
Topical 5-fluorouracil may be used in selected cases, especially when doctors are trying to treat very surface-level disease or reduce cancer cells near the lesion. It is not the standard first treatment for deeper plantar verrucous skin carcinoma, and results can be uneven.
Imiquimod is a skin-applied medicine that helps the immune system react against abnormal cells. It has been used in some verrucous skin cancers, but evidence is limited, so it is usually considered only in carefully chosen situations.
Bleomycin or interferon has sometimes been injected directly into the tumor when local treatment is needed and surgery is difficult. These approaches are not routine, and response can vary from one person to another.
Cemiplimab and pembrolizumab are medicines that help the immune system recognize and attack cancer cells. They are mainly used for advanced squamous cell skin cancers, so they may be considered if plantar verrucous skin carcinoma cannot be removed fully or has spread.
Genetic influences
At present, plantar verrucous skin carcinoma is not known to have a clear inherited pattern or one specific gene that explains most cases. It’s natural to ask whether plantar verrucous skin carcinoma runs in families. In most cases, the DNA changes linked to this rare skin cancer are thought to develop in the skin cells of the sole over time, rather than being passed down from a parent. Because of that, inherited genetic testing is not usually a routine part of care for plantar verrucous skin carcinoma. Still, if many close relatives have had repeated skin cancers, several rare cancers, or cancers at unusually young ages, your doctor may review the family history more closely. For many living with plantar verrucous skin carcinoma, doctors focus more on the tumor itself and on other possible contributors, such as long-standing irritation or chronic skin damage on the foot, than on a proven inherited cause.
Is Plantar verrucous skin carcinoma genetic?
Genetics are not thought to be a major driver of plantar verrucous skin carcinoma. Unlike some cancers, inherited genetic variations have not been clearly linked, and risk seems more related to long-term local skin changes and environmental factors.
Having a genetic risk is not necessarily a diagnosis
Across the general population, genetic changes are common and are a normal part of human biology. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, having a change associated with a condition suggests a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-studied change in a particular gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with plantar verrucous skin carcinoma, treatment decisions usually depend more on the size and depth of the growth, its exact spot on the sole, and whether it has come back than on inherited genes. This is because the main treatment is often complete removal, and there is no standard genetic test that routinely guides first-line care for plantar verrucous skin carcinoma. Genetics is only one factor, and in this condition it often matters more when the cancer is unusual, recurrent, or has spread. In those situations, doctors may sometimes test the tumor itself for changes in its cancer cells, which can occasionally help when considering drug treatment used for advanced skin cancers, including immunotherapy. Inherited pharmacogenetic testing, which looks at how your body handles medicines, is not a routine part of treatment options for plantar verrucous skin carcinoma. If your care team suggests genetic testing for plantar verrucous skin carcinoma, it is usually to answer a specific treatment question rather than because genetics drives most cases.
Interactions with other conditions
Plantar verrucous skin carcinoma can be harder to spot when it develops alongside more common foot problems, especially long-standing warts, calluses, or diabetic foot ulcers. Someone might notice their symptoms flare when another condition is active, such as swelling, repeated skin breakdown, or pain from pressure while walking, which can make the cancer look like a stubborn sore instead of something more serious. In people with diabetes, poor circulation, or nerve damage in the feet, healing may be slower and the area may be less painful than expected, so changes can be missed for longer. Long-term irritation or chronic wounds in the sole can also add to the problem, because the skin may stay inflamed and abnormal over time. People living with plantar verrucous skin carcinoma may also need closer follow-up if they have a weakened immune system, since unusual skin growths can be harder to control and may be mistaken for infection. If a foot lesion keeps coming back or does not improve with usual treatment, it is important to have it checked, because the early symptoms of plantar verrucous skin carcinoma can overlap with several noncancerous foot conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Plantar verrucous skin carcinoma?
A stubborn plantar wart, a thick callus or corn, and a long-lasting sore on the bottom of the foot can all look a lot like plantar verrucous skin carcinoma because they may cause a rough, thick, painful area that can crack, drain, or bleed. In some cases, other skin cancers on the foot, especially a more typical form of squamous cell skin cancer, can also look similar, which is why a doctor may need to examine the area closely and sometimes test a small sample.
History
People living with plantar verrucous skin carcinoma often first hear about it after months or even years of dealing with what seems like a stubborn wart or thickened patch on the sole. This slow-growing skin cancer has a long history of being mistaken for more common foot problems, especially when it starts as a rough area that makes walking uncomfortable or leaves the feeling that there is always a pebble in the shoe.
In recent decades, awareness has grown because doctors came to recognize that some deeply warty growths on the foot behave differently from ordinary plantar warts. First described in the medical literature as epithelioma cuniculatum, plantar verrucous skin carcinoma was identified as a distinct, very slow-growing form of skin cancer that tends to push into nearby tissue rather than spread quickly through the body. That helped explain why many earlier cases were overlooked or treated as harmless skin changes for long periods.
Before modern biopsy methods became routine, people with plantar verrucous skin carcinoma were often treated repeatedly for corns, calluses, chronic infections, or plantar warts. Someone might have had part of a thick sole lesion pared down again and again, only for it to return and gradually enlarge. Not every early description was complete, yet these reports helped doctors see a pattern: the growth was often bulky, warty, and persistent, and it could tunnel into the deeper skin of the foot.
As medical science evolved, pathologists became better at telling this condition apart from benign warts and from other, more aggressive skin cancers. Over time, the way the condition has been understood has changed, but one message stayed the same: a long-standing sole lesion that keeps growing deserves careful evaluation. This shift in understanding improved diagnosis and helped prevent delays in treatment.
Today, the history of plantar verrucous skin carcinoma also shapes how doctors think about early symptoms of plantar verrucous skin carcinoma. Because it is rare and usually grows slowly, it can still be missed at first. Knowing that history helps explain why a biopsy is often needed when a foot lesion does not heal, keeps coming back, or starts to interfere with daily walking.